Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Virbac Capital/Financing Update 2024

Jul 11, 2024

1753_rns_2024-07-11_ac442c8b-5e35-4712-9475-d6f92f364e99.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

TERMINATION OF THE LIQUIDITY CONTRACT

We inform you of the termination of our liquidity contract since July 1st, 2024.

This contact was in place since February 19, 2019 and suspended since February 3rd, 2023.

A lifelong commitment to animal health

At Virbac, we provide innovative solutions to veterinarians, farmers and animal owners in more than 100 countries around the world. Covering more than 50 species, our range of products and services enables us to diagnose, prevent and treat the majority of pathologies. Every day, we are committed to improving the quality of life of animals and to shaping the future of animal health together.

Virbac: Euronext Paris - subfund A – ISIN code: FR0000031577 / MNEMO: VIRP Financial Affairs Department: tel. 04 92 08 71 32 - email: [email protected] - Website: corporate.virbac.com